The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes.
HIV-1 establishes infection in astrocytes and macroage-lineage cells of the central nervous system (CNS). Certain antiretroviral drugs (ARVs) can penetrate the CNS, and are therefore often used in neurologically active combined antiretroviral therapy (Neuro-cART) regimens, but their relative activit...
Main Authors: | Lachlan R Gray, Gilda Tachedjian, Anne M Ellett, Michael J Roche, Wan-Jung Cheng, Gilles J Guillemin, Bruce J Brew, Stuart G Turville, Steve L Wesselingh, Paul R Gorry, Melissa J Churchill |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23614033/pdf/?tool=EBI |
Similar Items
-
Equilibrium solubility versus intrinsic dissolution: characterization of lamivudine, stavudine and zidovudine for BCS classification
by: André Bersani Dezani, et al.
Published: (2013-12-01) -
Stability-indicating methods for quantitative determination of zidovudine and stavudine in capsules
by: Maria Inês R. M. Santoro, et al.
Published: (2006-04-01) -
HIV-1 entry and trans-infection of astrocytes involves CD81 vesicles.
by: Lachlan R Gray, et al.
Published: (2014-01-01) -
Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.
by: Yu Cong, et al.
Published: (2016-01-01) -
DEVELOPMENT OF ELECTROANALYTICALS METODOLOGY FOR DETERMINATION OF ZIDOVUDINE, LAMIVUDINE AND ZALCITABINE
by: KATIA CHRISTINA LEANDRO ANTUNES
Published: (2004)